Barclays Reiterates “Equal Weight” Rating for Universal Health Services (NYSE:UHS)

Posted by Brenda Bartman on Jul 8th, 2026

Universal Health Services (NYSE:UHS – Get Free Report)‘s stock had its “equal weight” rating restated by analysts at Barclays in a report released on Wednesday,Benzinga reports. They presently have a $179.00 target price on the health services provider’s stock. Barclays‘s price target would indicate a potential upside of 10.80% from the stock’s previous close.

A number of other equities research analysts have also recently issued reports on UHS. Mizuho decreased their target price on Universal Health Services from $267.00 to $230.00 and set an “outperform” rating for the company in a research report on Wednesday, April 29th. Robert W. Baird reduced their price objective on shares of Universal Health Services from $241.00 to $204.00 and set a “neutral” rating for the company in a research note on Wednesday, April 29th. Cantor Fitzgerald decreased their price objective on shares of Universal Health Services from $229.00 to $194.00 and set a “neutral” rating for the company in a report on Wednesday, April 29th. Morgan Stanley lowered their target price on shares of Universal Health Services from $233.00 to $212.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 29th. Finally, Guggenheim dropped their target price on shares of Universal Health Services from $238.00 to $211.00 and set a “buy” rating on the stock in a report on Wednesday, April 29th. Five research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $212.88.

Check Out Our Latest Report on Universal Health Services

Universal Health Services Trading Up 2.2%

Universal Health Services stock opened at $161.55 on Wednesday. Universal Health Services has a one year low of $140.08 and a one year high of $246.32. The company’s fifty day moving average price is $155.09 and its two-hundred day moving average price is $186.19. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.08 and a quick ratio of 1.01. The company has a market capitalization of $9.78 billion, a price-to-earnings ratio of 6.73, a PEG ratio of 0.84 and a beta of 1.07.

Universal Health Services (NYSE:UHS – Get Free Report) last released its quarterly earnings results on Tuesday, April 28th. The health services provider reported $5.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.41 by $0.21. Universal Health Services had a return on equity of 19.57% and a net margin of 8.56%.The company had revenue of $4.50 billion during the quarter, compared to the consensus estimate of $4.39 billion. During the same quarter in the prior year, the company posted $4.84 EPS. The firm’s revenue was up 9.6% on a year-over-year basis. On average, analysts forecast that Universal Health Services will post 23.47 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Universal Health Services

Several hedge funds have recently made changes to their positions in UHS. Norges Bank acquired a new position in shares of Universal Health Services in the 4th quarter worth approximately $199,334,000. Pzena Investment Management LLC lifted its position in shares of Universal Health Services by 31.5% during the 4th quarter. Pzena Investment Management LLC now owns 2,112,604 shares of the health services provider’s stock worth $460,590,000 after buying an additional 505,575 shares during the period. Nomura Holdings Inc. boosted its stake in Universal Health Services by 100.6% in the 2nd quarter. Nomura Holdings Inc. now owns 2,560 shares of the health services provider’s stock valued at $464,000 after buying an additional 426,211 shares in the last quarter. Morgan Stanley boosted its stake in Universal Health Services by 59.5% in the 4th quarter. Morgan Stanley now owns 871,377 shares of the health services provider’s stock valued at $189,978,000 after buying an additional 325,162 shares in the last quarter. Finally, Holocene Advisors LP grew its position in Universal Health Services by 262.4% in the third quarter. Holocene Advisors LP now owns 358,885 shares of the health services provider’s stock valued at $73,370,000 after acquiring an additional 259,861 shares during the period. Institutional investors own 86.05% of the company’s stock.

About Universal Health Services

(Get Free Report)

Universal Health Services, Inc (NYSE: UHS) is one of the largest diversified health care management companies in the United States, offering a broad spectrum of services through its acute care hospital and behavioral health segments. The company operates general acute care hospitals, surgical hospitals and ambulatory centers, as well as inpatient and outpatient behavioral health facilities. Its network provides emergency and specialized medicine, diagnostic imaging, laboratory services, advanced surgical care and rehabilitation, complemented by a comprehensive array of behavioral services including psychiatric treatment, addiction programs and developmental disabilities care.

In the acute care segment, UHS’s facilities deliver services ranging from emergency department treatment and intensive care to maternity care and outpatient surgery.